Australian Dream Back Pain

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Australian Dream Back Pain
Generic name: HISTAMINE DIHYDROCHLORIDE
Manufacturer: Sombra Cosmetics Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 5256a63e-e6da-84c1-e063-6294a90a8dff
SPL ID: 5256a63e-e6db-84c1-e063-6294a90a8dff
Version: 1
Effective date: 2026-05-21
Source export date: 2026-10-27
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/be847f9aea8d80a2cb7e9771acd1143be084664192ecf8f5be8ac1024116f4f0/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 20:14:56

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 21 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Australian Dream Back Pain	openfda.brand_name
generic name		HISTAMINE DIHYDROCHLORIDE	openfda.generic_name
manufacturer name		Sombra Cosmetics Inc.	openfda.manufacturer_name
ndc	package	61577-8121-8	openfda.package_ndc
ndc	package	61577-8121-4	openfda.package_ndc
ndc	package	61577-8121-5	openfda.package_ndc
ndc	package	61577-8121-9	openfda.package_ndc
ndc	package	61577-8121-2	openfda.package_ndc
ndc	package	61577-8121-3	openfda.package_ndc
ndc	product	61577-8121	openfda.product_ndc
ndc11	package	61577812104	derived:openfda.package_ndc
ndc11	package	61577812103	derived:openfda.package_ndc
ndc11	package	61577812105	derived:openfda.package_ndc
ndc11	package	61577812102	derived:openfda.package_ndc
ndc11	package	61577812109	derived:openfda.package_ndc
ndc11	package	61577812108	derived:openfda.package_ndc
rxcui		1542820	openfda.rxcui
spl id		5256a63e-e6db-84c1-e063-6294a90a8dff	id
spl set id		5256a63e-e6da-84c1-e063-6294a90a8dff	set_id
unii		3POA0Q644U	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Section For external use only. Do not use on wounds or damaged skin or if you are allergic to ingredients in this product. When using this product: avoid contact with eyes. If product gets into eyes, rinse thoroughly with water. Do not bandage tightly or use a heating pad. Stop use and ask doctor if: rash appears. Condition worsens. If symptoms persist for more than 7 days or if symptoms clear up and occur again within a few days. If pregnant or breast feeding, ask a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.